Read More

Lifecore Biomedical Enters Into $150M In New Financing, Repays its Outstanding Term Loans And Signs New Supply Agreement To Expand HA Fermentation Capacity With Existing Long-Term Customer, Alcon

Lifecore Biomedical, Inc. (NASDAQ:LFCR), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has entered into a broad set of agreements with its long-term customer,

ALC